MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Imaging Analysis of the International Tourette Syndrome Deep Brain Stimulation Registry and Database

    K. Johnson, D. Servello, M. Porta, A. Bona, J. Ostrem, E. Bardinet, ML. Welter, A. Lozano, J.C. Baldermann, J. Kuhn, D. Huys, T. Foltynie, M. Hariz, E. Joyce, L. Zrinzo, Z. Kefalopoulou, JG. Zhang, FG. Meng, C. Zhang, Z. Ling, A. Smeets, L. Ackermans, V. Visser-Vandewalle, A. Mogilner, M. Pourfar, W. Hu, A. Gunduz, K. Foote, M. Okun, C. Butson (Salt Lake City, UT, USA)

    Objective: We performed a retrospective analysis of Tourette syndrome (TS) patients receiving deep brain stimulation (DBS) therapy as part of the Tourette Association of America…
  • 2018 International Congress

    Motor speech and swallowing phenotype of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)

    A. Vogel, N. Rommel, A. Oettinger, L. Stoll, E-M. Kraus, C. Gagnon, P. Krumm, M. Horger, D. Timmann, E. Storey, L. Schöls, M. Synofzik (Melbourne, Australia)

    Objective: To provide a comprehensive quantitative and qualitative characterization of speech and swallowing function in ARSACS to support diagnostics, provide insights into the underlying pathology,…
  • 2018 International Congress

    MicroRNAs Unveil Metabolic Imbalance in Spinocerebellar Ataxia Type-2

    V. Swarup, R. Singh, H. Singh, I. Singh, M. Faruq, S. Vivekanandhan, A. Srivastava (New Delhi, India)

    Objective: To correlate differentially expressed non-coding microRNA of peripheral blood mononuclear cells (PBMCs) with SCA2 pathogenesis. Background: Spinocerebellar ataxia aype-2 (SCA2), the most common SCA…
  • 2018 International Congress

    Open-label pilot trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)

    D. Hall, E. Robertson, M. Leehey, A. McAsey, B. Ouyang, E. Berry-Kravis, J. O'Keefe (Chicago, IL, USA)

    Objective: To determine if citicoline was safe and effective for treatment of tremor and balance abnormalities and stabilization of cognitive decline in patients with FXTAS.…
  • 2018 International Congress

    Influence of disease progression on the quality of life of individuals with spinocerebellar ataxia type 10

    L. Santos, M. Zonta, H. Teive, N. Mello, F. Neto, A. Macedo (Curitiba, Brazil)

    Objective: To evaluate quality of life (QoL) of individuals with Spinocerebellar Ataxia Type 10 (SCA10) and investigate whether there is an association between self-perception and…
  • 2018 International Congress

    Chorea and Ataxia as Manifestations of Xeroderma Pigmentosum: A Case Report

    A. Jocson, K. Ngo, D. Togasaki, B. Fogel (Los Angeles, CA, USA)

    Objective: To report a case of a 51-year-old woman with recurrent basal cell carcinoma, severe photosensitivity, and progressive chorea and ataxia caused by xeroderma pigmentosum…
  • 2018 International Congress

    Effects of a combined approach with botulinum toxin (BONT) and motor-learning techniques (MLT) on sensori-motor functional connectivity in patients with cervical dystonia (CD)

    A. Castagna, M. Cabinio, M. Ramella, L. Magistrelli, M. Laganà, F. Baglio (Milano, Italy)

    Objective: Aim of this study is to evaluate sensori-motor connectivity associated with a multimodal BoNT/MLT teratment in CD patients using advanced Resonance Imaging (MRI) techniques.…
  • 2018 International Congress

    Prevalence and Correlates of Anxiety & Depression in Cervical Dystonia

    M. Al Hussona, I. Ndukwe, S. O'Riordan, R. Beck, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: Our aim was to assess the prevalence and severity of mood disorder in our Cervical Dystonia population attending the botulinum toxin clinic and to…
  • 2018 International Congress

    Generation and in-depth characterization of induced pluripotent stem cell (iPSC) lines from 10 affected and unaffected carriers of THAP1 mutations

    H. Baumann, M. Trilck, M. Jahn, A. Münchau, V. Kostic, C. Klein, P. Seibler, K. Lohmann (Luebeck, Germany)

    Objective: To establish induced pluripotent stem cells (iPSCs) of affected and unaffected Mutation carriers to investigate disease mechanisms of THAP1 in dystonia. Background: Mutations in…
  • 2018 International Congress

    A Registry of Real-World Outcomes Using Deep Brain Stimulation for the Treatment of Dystonia

    J. Krauss, C. Nicholson, M. Barbe, V. Visser-Vanderwalle, A. Kuehn, M. Poetter-Nerger, R. Jain, H. Scholtes, N. Van Dyck, A. Albanese (Hannover, Germany)

    Objective: The objective of this device registry entails collecting clinical outcomes, economic value and technical performance of a Deep Brain Stimulation (DBS) system capable of…
  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley